JW Lifescience Corporation (KRX:234080)
South Korea · Delayed Price · Currency is KRW 10,520
+20 (0.19%)
Oct 23, 2026, 3:30 PM KST
JW Lifescience Market Cap
JW Lifescience has a market cap or net worth of 162.9 billion as of October 23, 2026. It is the 23,710th most valuable company in the world and the 952nd biggest in South Korea. Its market cap has decreased by 21.49% in one year.
Market Cap
162.90B
Enterprise Value
183.18B
Revenue
253.71B
Global Rank
Country Rank
#952 South Korea
PE Ratio
6.26
ChartMarket Cap Chart
Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 162.90B, a decrease of -52.10%. That is a compound annual growth rate of -7.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 162.90B | -18.13% |
| Dec 30, 2025 | 198.98B | 18.11% |
| Dec 30, 2024 | 168.47B | -15.46% |
| Dec 28, 2023 | 199.29B | 5.93% |
| Dec 29, 2022 | 188.14B | -12.27% |
| Dec 30, 2021 | 214.46B | -34.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yungjin Pharm. | 180.33B |
| REYON Pharmaceutical | 178.64B |
| Samil Pharmaceutical Co.,Ltd | 175.88B |
| AptaBio Therapeutics | 175.30B |
| BNC KOREA | 175.09B |
| Daewon Pharmaceutical | 170.18B |
| Chong Kun Dang Holdings | 169.24B |
| Ilsung Is | 149.83B |